The antimalarial drug hydroxychloroquine is being widely promoted as a “cure” for COVID-19, but we still lack good data on its true benefits.Some small clinical trials have shown possible benefits. But others have shown the opposite.Complicating matters, two major studies have been retracted over issues with data. The FDA reissued a warning that people shouldn’t take the drug without a doctor’s supervision
